Abstract
Thirty-nine patients with uncomplicated gonorrhea were randomized to receive single, oral 50-, 100-, or 200-mg doses of trovafloxacin (CP-99,219), a new quinolone antibiotic. All 31 evaluable patients were cured of infection. Trovafloxacin was well tolerated. The trovafloxacin MICs at which 50 and 90% of 36 Neisseria gonorrhoeae isolates are inhibited were 0.002 and 0.004 mg/liter, respectively (MIC range, < 0.0005 to 0.008 mg/liter). These preliminary studies suggest that trovafloxacin is effective for the treatment of uncomplicated gonorrhea at single oral doses as low as 50 mg.
Full Text
The Full Text of this article is available as a PDF (195.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hook E. W., 3rd, Jones R. B., Martin D. H., Bolan G. A., Mroczkowski T. F., Neumann T. M., Haag J. J., Echols R. Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women. Antimicrob Agents Chemother. 1993 Aug;37(8):1670–1673. doi: 10.1128/aac.37.8.1670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knapp J. S., Neal S. W., Parekh M. C., Rice R. J. In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1995 Apr;39(4):987–989. doi: 10.1128/aac.39.4.987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nuutinen M., Turtinen J., Uhari M. Growth and joint symptoms in children treated with nalidixic acid. Pediatr Infect Dis J. 1994 Sep;13(9):798–800. doi: 10.1097/00006454-199409000-00009. [DOI] [PubMed] [Google Scholar]
- Reichart C. A., Neumann T., Foreman P., Zenilman J. M., Hook E. W., 3rd Temporal trends in gonococcal antibiotic resistance in Baltimore. Sex Transm Dis. 1992 Jul-Aug;19(4):213–218. doi: 10.1097/00007435-199207000-00006. [DOI] [PubMed] [Google Scholar]
- Schwarcz S. K., Zenilman J. M., Schnell D., Knapp J. S., Hook E. W., 3rd, Thompson S., Judson F. N., Holmes K. K. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA. 1990 Sep 19;264(11):1413–1417. [PubMed] [Google Scholar]
- Whittington W. L., Knapp J. S. Trends in resistance of Neisseria gonorrhoeae to antimicrobial agents in the United States. Sex Transm Dis. 1988 Oct-Dec;15(4):202–210. doi: 10.1097/00007435-198810000-00006. [DOI] [PubMed] [Google Scholar]